Ricursive Intelligence, founded by two former Google researchers and valued at $4 billion, is among several efforts to ...
Tempus AI's diagnostics segment shows strong pricing power, with Oncology ASP rising from $1,630 to over $2,200. Read why TEM ...
While standard models suffer from context rot as data grows, MIT’s new Recursive Language Model (RLM) framework treats ...
Abstract: The minimum error entropy (MEE) criterion closely relies on the quadratic information potential (QIP) estimates of Renyi’s entropy. Nevertheless, the ...
Abstract: This article investigates a fixed-time adaptive fuzzy containment control problem for six-rotor multi-UAVs with flight route constraints and external disturbances. An effective adaptive ...
Recursion Pharmaceuticals' AI-based approach has the potential to transform the pharmaceutical industry. However, it is still chasing clinical wins that would demonstrate the power of its strategy.